{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaojaiy25kxqsgzzyxqusv4bdbhz7i66nxq3mlker7prasvim2iiq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mlkyfuaibz22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibltdpakbfotx27v5zoeg5jsvm3jwvhuaxtke6n5vokbwhakzgaey"
    },
    "mimeType": "image/jpeg",
    "size": 137558
  },
  "path": "/2026/05/11/astellas-gene-therapy-trials-resume-promising-myotubular-myopathy-treatment/?utm_campaign=rss",
  "publishedAt": "2026-05-11T08:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Health",
    "Pharma",
    "FDA",
    "gene editing",
    "Gene therapy",
    "rare diseases",
    "research",
    "STAT+"
  ],
  "textContent": "Some boys had astonishing recoveries. But other boys died. Now Astellas is returning to revised gene therapy for XLMTM.",
  "title": "STAT+: Five years after disaster, a rare disease community gets new chance at treatment",
  "updatedAt": "2026-05-11T03:43:46.000Z"
}